Revolutionizing Healthcare: Global Cryopreservation Market on the Fast Track to USD 50 Billion

Cleveland Street, VA, United States, June 27, 2025 — The global cell cryopreservation technologies is witnessing rapid growth, fueled by rising infertility rates, increasing demand for personalized therapies, and advancements in regenerative medicine and biobanking services. According to a new research report from Markets & Data, the global cell cryopreservation market was valued at USD 11.19 billion in 2024 and is expected to reach USD 50.88 billion by 2032, growing at a robust CAGR of 21.0% during the forecast period.

Cell cryopreservation, a critical technology that preserves cells for long-term storage at extremely low temperatures, is essential for numerous applications in regenerative medicine, stem cell research, fertility preservation, and vaccine production.  Sharing his thoughts on the report, Vivek Gupta, Managing Director, Markets & Data, added, “The global cell cryopreservation market is at the cusp of a transformative phase, driven by advancements in regenerative medicine, personalized therapies, and the growing need for fertility preservation services. As technological innovations continue to improve cell viability and storage, there is a significant demand for cell cryopreservation, positioning this market for substantial growth in the coming years."

Key Drivers of Growth:

1. Personalized Therapies and Regenerative Medicine:
   Technological advancements and increased demand for personalized healthcare are boosting the need for cryopreserved cells. The rising acceptance to preserve stem cells, combined with the growing focus on regenerative medicine, are significant contributors to the market's expansion.
2. Infertility and Fertility Preservation Services:
   Infertility rates have been steadily increasing globally, leading to a surge in demand for fertility preservation services such as egg and sperm cryopreservation. Societal trends, including delayed parenthood due to career and financial stability concerns, further drive the need for cell cryopreservation solutions.
3. Technological Advancements:
   Innovations in cryopreservation techniques, including advanced freezing protocols, cryoprotectants, and automation, are enhancing cell viability and ensuring more efficient preservation. These advancements are crucial for improving the quality and precision of cell storage and thawing processes.
4. Aging Population and Biobanking Services:
   The rapid growth of the aging population, particularly in developed regions such as North America and Europe, is accelerating the demand for biobanking services. Biobanks, which store biological samples for future use, heavily rely on cryopreserved cells for research, regenerative medicine, and therapeutic applications.

Regional Outlook:

North America holds the largest share of the global market, primarily due to its advanced healthcare infrastructure and growing acceptance of fertility preservation technologies. However, the Asia-Pacific region is expected to witness the highest growth during the forecast period. Factors driving this growth include the rising rates of infertility, government support for fertility preservation programs, and the increasing adoption of advanced healthcare technologies.

Key Players and Strategic Developments:

Leading players in the global cell cryopreservation market include Merck & Co., Inc., Thermo Fisher Scientific Inc., Lonza Group Ltd., GE HealthCare Technologies Inc., and BioLife Solutions Inc.. These companies are focusing on expanding their product portfolios and investing in R&D to enhance cryopreservation techniques and improve cell viability.

In April 2024, Thermo Fisher Scientific Inc. launched a new line of ultra-low temperature freezers designed to enhance performance, user experience, and energy efficiency, ensuring optimal cell preservation for clinical and research applications.

Market Insights:

The report also highlights key market segments based on product, application, end-user, and region. Among products, consumables, such as cryogenic vials and freezing media, hold a significant market share due to their critical role in preserving biological samples. Stem cells dominate the application segment, driven by their pivotal role in regenerative medicine and ongoing research into chronic disease treatments.

About the Report:

The "Global Cell Cryopreservation Market Assessment, Opportunities, and Forecast, 2018-2032F" report offers an in-depth analysis of the market, including the latest trends, technological advancements, and regional insights. It provides a comprehensive overview of the key drivers, challenges, and opportunities shaping the future of cell cryopreservation.

About Markets & Data:

Markets & Data is a leading B2B research and intelligence firm that provides actionable insights across industries such as healthcare, automotive, technology, and energy. The company offers syndicated and custom reports designed to help businesses stay competitive and data-driven in the evolving global market.

For more information or to download a sample report, visit Markets & Data.

Contact
Mr. Vivek Gupta
5741 Cleveland street,
Suite 120, VA beach, VA, USA 23462
Tel: +1 (757) 343-3258
Email: info@marketsandata.com
Website: https://www.marketsandata.com